Notice dated 7 May 2026. This page written and reviewed 12 October 2026.
On 7 May 2026, Health Canada published a recall of two peptide powders. It listed the recall as Type I, in the category of drugs, and gave one reason: the products sold were unauthorized active pharmaceutical ingredients. In plain words, the notice files powders sold as raw ingredients under drugs, not outside the drug rules.
This page walks through the recall notice. The notice names the company that recalled the products; we do not.
What the notice says
The recall's title names the two products:
"GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients"
Health Canada recall, 7 May 2026, title, retrieved 12 October 2026.
The notice lists the recall date as 5 May 2026, the date published as 7 May 2026, the recall class as Type I and the category as "Health products - Drugs". Its statement of the issue is one line:
"Products sold are unauthorized active pharmaceutical ingredients (APIs)."
Health Canada recall, 7 May 2026, issue, retrieved 12 October 2026.
Both names in the title also appear in Health Canada's April 2026 advisory, in its list of examples of unauthorized peptide drugs it had seized; see the April 2026 advisory, explained.
What an "active pharmaceutical ingredient" is
Health Canada explains the term in its questions and answers on good manufacturing practices:
"The active ingredient in a pharmaceutical drug is called an active pharmaceutical ingredient (API)."
Health Canada, Active Pharmaceutical Ingredients: Good Manufacturing Practices, Questions and Answers, retrieved 12 October 2026.
So an API is the substance that makes a drug a drug, before it is made into a finished product. The recall calls these powders unauthorized APIs: the active substance itself, sold without authorization.
Why a powder is not outside the rules
It is easy to assume that a raw powder, not packed as a finished product, sits outside the drug rules. The recall's own category, "Health products - Drugs", points the other way. The Food and Drug Regulations also cover importing for sale any food or drug whose sale would break the rules:
"A.01.040 Subject to section A.01.044, no person shall import into Canada for sale a food or drug the sale of which in Canada would constitute a violation of the Act or these Regulations."
Food and Drug Regulations (C.R.C., c. 870), retrieved 4 October 2026.
And Health Canada's April 2026 advisory addressed labels that try to put products outside the rules:
"Health Canada continues to identify products marketed as “For Research Use Only – Not for Human Consumption.” This type of labelling does not make these products legal or exempt from regulatory requirements. Canadians are advised not to buy or use products labelled in this way."
Health Canada public advisory, 9 Apr 2026, retrieved 4 October 2026.
Read together, the notices give no sign that selling a peptide as a powder, as an ingredient or with a research-use label takes it outside the drug rules.
How it fits the 2026 notices
The recall sits between the April 2026 advisory and the July 2026 statement on a permanent injunction against a Canadian online seller. In order:
- 21 January 2026: an advisory on unauthorized GLP-1 products.
- 9 April 2026: the advisory on peptides bought online, with its list of seized examples.
- 7 May 2026: this recall of two powders as unauthorized APIs.
- 29 July 2026: the statement on the injunction.
The dated list, back to June 2024, is on Health Canada and peptides: the notices, dated.
What a reader can check
The check Health Canada points to in its April 2026 advisory is the same for any drug product:
"Check the label before you buy. Authorized prescription drugs in Canada have an eight-digit Drug Identification Number (DIN). You can also check whether a drug has been authorized for sale by searching Health Canada's Drug Product Database."
Health Canada public advisory, 9 Apr 2026, retrieved 4 October 2026.
Our page on DIN, NPN and how to check a product walks through the search.
This page reports a recall notice. It says nothing about any other seller or product, and it is not medical or legal advice.
New notices are added to the library as Health Canada publishes them. Get one email when a notice is added.
Sources
- Health Canada recall, 7 May 2026: "GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients", retrieved October 12, 2026
- Health Canada: Active Pharmaceutical Ingredients, Good Manufacturing Practices, Questions and Answers, retrieved October 12, 2026
- Health Canada public advisory, 9 Apr 2026: "Think twice before injecting peptides bought online: unauthorized products can seriously harm you", retrieved October 4, 2026
- Food and Drug Regulations (C.R.C., c. 870), retrieved October 4, 2026
Marked verified by the founder on October 15, 2026. Spotted an error? Tell us.